News & Events
 

All.Can Roundup # 1

Opinion roundup

 

Cancer prevention in all policies

  • Central cancer prevention strategy must involve creating an environment – through regulation, education and support programmes – that encourages individuals to adopt healthy behaviours.
  • Governmental responsibility extends beyond the function of traditional health-focused departments; agencies involved in environmental protection, occupational safety and transportation also have a role in cancer prevention.
  • Cancer prevention and health promotion are also in the realm of the zoning board, the board of education, and the board of health.

http://www.thelancet.com/pdfs/journals/lanonc/PIIS1470-2045(17)30374-1.pdf

 

The science of precision prevention of cancer

  • ‘Precision prevention’ could give the false impression of a curative or preventive power that is absent when transferred into practice. Availability of the tools should not be confused with achievement of the goal.
  • Application of precision to prevention can be very complex, including identification of individuals who might benefit. The number-needed-to-treat (NNT) might be quite high, having an impact on cost-effectiveness.
  • There is a risk that the much-needed shift to redress the imbalance between cancer prevention and treatment may be replaced by a search for a medical solution for all impending ills, combined with a resulting imbalance between the emphasis on the population and high-risk groups.

http://www.thelancet.com/journals/lanonc/article/PIIS1470-2045(17)30331-5/fulltext?elsca1=etoc

 

Research roundup

 

Burden and centralised treatment in Europe of rare tumours: results of RARECAREnet—a population-based study

  • Survival has increased for most rare cancers, with the largest increases for haematological tumours and sarcomas.
  • The amount of centralisation of rare cancer treatment varied widely between cancers and between countries. The Netherlands and Slovenia had the highest treatment volumes.
  • Survival could be improved by early diagnosis, new treatments, and improved case management. The centralisation of treatment could be improved in the seven European countries studied.

http://www.thelancet.com/journals/lanonc/article/PIIS1470-2045(17)30445-X/fulltext?elsca1=etoc

 

Developing a model for Integrated Care in Prostate Cancer (ICARE-P)

  • Prostate cancer requires innovative approaches of care delivery, strengthening collaboration and interoperability, linking the patient and the healthcare team.
  • This was a two-phase study. Firstly, input from healthcare professionals and patients was used to refine the intervention. Secondly, a randomised controlled trial was conducted of an integrated follow-up care model using digital technology. In Phase 1, researchers developed an online adaptive prostate-specific Holistic Needs Assessment system, training for staff and qualitative interviews.
  • The study found that men strongly supported the intervention, even if they had low digital literacy.
  • Primary care clinicians endorsed the need for improved communication with specialists (highlighting their current frustration).
  • The study demonstrated slow adoption of digital technology in secondary care compared with primary care. Barriers included concerns about data security and a lack of attention to the needs of end users.

http://www.researchprotocols.org/2017/7/e147/

 

Aggressive end-of life care may not improve survival time of women with metastatic breast cancer

  • This study analysed factors associated with aggressive end-of-life care, and evaluated economic and survival time outcomes.
  • Patients who lived more than 12 months after diagnosis were more likely to utilise hospices and less likely to receive aggressive end-of-life care.
  • Patients with a shorter survival time had significantly higher costs of care per month alive, compared with patients with a longer survival time.

https://www.ncbi.nlm.nih.gov/pubmed/28752188

 

Policy and initiatives roundup

 

EU Horizon 2020

 

UK Cancer Patient Experience survey: patients feel increasingly positive about their care

  • 87.5% of patients in the National Cancer Patient Experience Survey 2016 said they had their cancer tests at the right time, up from 86.6% the previous year.
  • 78% of respondents said that they were definitely involved as much as they wanted to be in decisions about their care.

https://www.england.nhs.uk/2017/07/cancer-patient-survey/

 

NHS England launching plan to drive out wasteful and ineffective drug prescription

  • The English health service has launched a consultation on new national guidelines stating that treatments including homeopathy and herbal treatments should generally not be prescribed.
  • The consultation also covers 3,200 prescription items, many of which are available direct to the public through retail outlets and pharmacies at a far lower price than the cost to the NHS.
  • It is estimated that ending prescription of these treatments would saving the NHS more than £190 million per year, which the service could then reinvest in more effective treatments.
  • NHS England Medical Director Sir Bruce Keogh said: ‘We need to end unnecessary expense to give us a bigger therapeutic bang for the NHS buck.’

https://www.england.nhs.uk/2017/07/medicine-consultation/

#AllCanRoundup